Mirae Asset Global ETFs Holdings
AGIO icon

Mirae Asset Global ETFs Holdings’s Agios Pharmaceuticals AGIO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Sell
41,455
-616
-1% -$18.7K ﹤0.01% 1391
2026
Q1 		$1.39M Buy
42,071
+2,616
+7% +$74.2K ﹤0.01% 1354
2025
Q4 		$1.07M Buy
39,455
+2,863
+8% +$100K ﹤0.01% 1473
2025
Q3 		$1.47M Sell
36,592
-2,987
-8% -$112K ﹤0.01% 1283
2025
Q2 		$1.32M Sell
39,579
-3,748
-9% -$114K ﹤0.01% 1300
2025
Q1 		$1.27M Buy
43,327
+2,920
+7% +$96.9K ﹤0.01% 1374
2024
Q4 		$1.33M Buy
40,407
+283
+0.7% +$13.3K ﹤0.01% 1395
2024
Q3 		$1.79M Buy
40,124
+3,984
+11% +$181K ﹤0.01% 1197
2024
Q2 		$1.56M Buy
+36,140
New +$1.3M ﹤0.01% 1206

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Mirae Asset Global ETFs Holdings's AGIO Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Agios Pharmaceuticals (AGIO) stake by 1.5% in Q2 2026, selling an estimated $18.7K and leaving 41,455 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

Mirae Asset Global ETFs Holdings first reported a position in AGIO in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.79M in Q3 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 41,455 shares of Agios Pharmaceuticals worth $1.54M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 616 Agios Pharmaceuticals shares in Q2 2026, an estimated $18.7K.
  • Agios Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1391 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Agios Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Agios Pharmaceuticals position peaked at $1.79M in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.